A Retrospective Case Series of Peripheral Mixed Nerve Reconstruction Failures Using Processed Nerve Allografts
- PMID: 35070612
- PMCID: PMC8769133
- DOI: 10.1097/GOX.0000000000003983
A Retrospective Case Series of Peripheral Mixed Nerve Reconstruction Failures Using Processed Nerve Allografts
Abstract
Background: Favorable rates of meaningful recovery (≥M3/S3) of processed nerve allografts (PNAs) for mixed and motor nerve injuries have been reported, but there are few reports of patients having complete PNA failure (M0/S0). The purpose of this study was to describe the outcomes, including rate of complete failures, in a case series of patients who underwent PNA for peripheral mixed nerve reconstructions.
Methods: A retrospective review of outcomes between May 2018 to September 2020 was performed. Consecutive patients who underwent nerve reconstruction (>15 mm) with PNA for a peripheral mixed nerve injury of the upper or lower extremity were eligible. Those who returned to clinic for a 10-month postoperative visit were included in this study. The primary outcome was whether the patient was defined as having a complete failure (M0/S0).
Results: A total of 22 patients underwent a PNA during the time period; 14 patients participated in follow-up and were included (average age: 34.7 years) with a mean follow-up of 11.9 months. The average gap length was 46.4 mm (range 15-110 mm). At their 10-month postoperative visit, no patients had any motor or sensory improvement; all patients were deemed as having complete failure. Four patients underwent or were planned for subsequent revision surgery.
Conclusions: In this study, we demonstrated a high number of complete failures, with all 14 included patients sustaining a complete failure (100% failure rate) at a minimum 10-month follow-up visit. Failure in this case series was not observed to affect one nerve type, location, or be related to preoperative injury size.
Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.
Conflict of interest statement
Disclosure: Dr. Steven Koehler is a committee member of the American Society for Surgery of the Hand (ASSH), a paid consultant and speaker for Integra LifeSciences, Inc, a paid consultant for Tissium, Inc., a stockholder and member of the medical advisory board for Reactiv, Inc., a member of the advisory board for Androes, LLC, and a speaker for TriMed, Inc. All the other authors declare no financial interest in relation to the content of this article. This study did not receive any grant.
Figures
References
-
- Giusti G, Willems WF, Kremer T, et al. . Return of motor function after segmental nerve loss in a rat model. J Bone Jt Surg. 2012;94:410–417. - PubMed
-
- Axogen. Avance Axogen. Published n.d. Accessed May 27, 2021. https://www.axogeninc.com/avance-nerve-graft/
-
- Cho MS, Rinker BD, Weber RV, et al. . Functional outcome following nerve repair in the upper extremity using processed nerve allograft. J Hand Surg Am. 2012;37:2340–2349. - PubMed
-
- Giusti G, Lee JY, Kremer T, et al. . The influence of vascularization of transplanted processed allograft nerve on return of motor function in rats. Microsurgery. 2016;36:134–143. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous